Skip to main content

Protecting Shareholder Value Today

Poison Pills and Takeover Defense Considerations During Pandemic Times


Date: July 8, 2020

Time: 1:00PM - 2:00PM (EST)

Location: View the Webinar Recording

History has shown that extreme stock market volatility often triggers a wave of unsolicited or hostile M&A activity and stockholder activism. Since March of this year, there has been a surge of companies adopting and publicly announcing shareholder rights plans (“poison pills”) to protect stockholders from such predatory activities. Should you be considering the same strategy? 

Mintz and Stifel discuss a number of strategic and tactical business, legal, and investment-related considerations, including:

  • Lessons learned from the 2020 proxy season and recent wave of poison pill adoptions — mistakes made and winning decisions
  • Understanding the modern, evolving role of the poison pill within a broader activism and takeover defense strategy
  • Managing internal discussions to drive smart decisions and mechanics for implementing rights plans


Matt regularly advises companies, board of directors, special committees, investment banks and investors in both buy and sell-side mergers and acquisitions and other strategic transactions. In addition, Matt counsels public companies on a broad range of corporate, securities and business-related matters, including capital-raising, fiduciary duties, corporate governance, SEC reporting and defensive measures.

Juan I. Bonifacino


Managing Director, Activism & Contested Situations, Stifel